AIV Logo AIV Assistant

Loading...

 Logo InMode Ltd. - INMD Open InMode Ltd. in new tab

14.71
P/E
6.55
EPS
2.38
P/B
1.57
ROE
0.26
Beta
2.09

14.7100

14.710

Daily: +2.51%
Key Metrics

Earnings date: Nov. 5, 2025

P/E: 6.55

EPS: 2.38

Book Value: 9.94

Price to Book: 1.57

Debt/Equity: 0.97

% Insiders: 0.106%

Growth

Revenue Growth: 0.11%

Earnings Growth: 0.50%

Estimates

Forward P/E: 7.35

Forward EPS: 2.12

 Logo About InMode Ltd. - (INMD)

Country: Israel

Sector: Health Care

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company sells and markets its products in the United States, Canada, the United Kingdom, Ireland, Spain, Portugal, France, Belgium, Luxemburg, Italy, Germany, Austria, Japan, Australia, and India through distributors. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokne'am, Israel.

Dividends

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion